Items where authors include "Salmenniemi, U."

Article

Garderet, L., Gras, L., Koster, L. et al. (23 more authors) (2024) Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Haematologica, 109 (8). ISSN 0390-6078

Scheid, C. orcid.org/0009-0007-6539-226X, Eikema, D.-J., van Gelder, M. orcid.org/0000-0001-8698-4351 et al. (27 more authors) (2024) Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood, 144 (4). pp. 445-456. ISSN 0006-4971

Robin, M. orcid.org/0000-0003-1388-9876, Iacobelli, S., Koster, L. et al. (22 more authors) (2024) Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 59 (7). pp. 928-935. ISSN 0268-3369

Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609

Duque-Afonso, J., Finke, J., Labopin, M. et al. (18 more authors) (2022) Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation, 57 (8). pp. 1269-1276. ISSN 0268-3369

Proceedings Paper

Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) Long term outcomes and renal response following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Cmwp of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 3403.

Robin, M., Iacobelli, S., Passweg, J.R. et al. (22 more authors) (2023) Treosulfan compared to Busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the chronic malignancies working party of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 473.

Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) P478: Long term outcomes following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the CMWP of the EBMT. In: Bone Marrow Transplant. 49th Annual Meeting of the European Society for Blood and Marrow Transplantation, 23-26 Apr 2023, Paris Hybrid Meeting. Springer Nature , p. 478.